About us

Background

DELPHINIUM is a boutique CRO based in Groningen, the Netherlands, with its own clinical research unit and in-house pharmacy. We offer high-quality, reliable clinical trial execution with a personal, hands-on approach. Our compact structure and experienced team allow us to operate with speed and flexibility, supported by competitive pricing and short start-up timelines: Ethics approval is typically achieved within 30 days.

We work in close collaboration with the University Medical Center Groningen, combining academic insight with operational excellence. Our expertise spans a wide range of studies, including PK/PD, First-in-Human, and bioequivalence trials. With over 60 years of combined experience and more than 50 completed clinical trials in both healthy volunteers and patient populations, we bring proven, practical knowledge to every phase. Our integrated setup which including an in-house pharmacy, ClinSpark eSource/EDC system, and location on hospital grounds ensures fast, agile, and controlled study execution.

I would absolutely recommend conducting clinical studies with DELPHINIUM based solely upon the breadth and expertise of the team I used to work with when they were still at another CRO. In addition, Delphinium’s proximity to UMC Groningen provided access to subject matter experts and specialists if needed, particularly within the realm of imaging. Moreover; a diverse and expansive population in the greater Groningen region lends itself to optimal trial recruitment ~ D. Jacobs, VP clinical Operations, Betagenon

Want to learn more about how it’s like to work with us?
Review our other testimonials.

Testimonials

Expertise

Our main focus is on early-phase studies in healthy volunteers, supporting a wide range of therapeutic areas. We have built particular expertise in:
• Cardiology
• Allergology
• Neurolog/CNS
• Metabolic Diseases
• Nephrology
• Rare Diseases

With decades of hands-on experience, our team knows how to design and run studies that deliver high-quality data, reliable outcomes, and faster timelines. Every project benefits from our scientific precision, proactive communication, and commitment to excellence.

Explore our publications to see our expertise in action.

See our publications

Our facility

DELPHINIUM’s Clinical Research Unit includes 12 beds and is equipped to support a variety of study designs. A central supervision room allows for continuous visual monitoring during high-risk studies. For lower-risk protocols and increased subject privacy, a separate smaller room is available. A private examination room is also on-site for specialized procedures.

The unit is located in Groningen, the Netherlands, on the campus of the University Medical Center Groningen (UMCG). This prime location offers access to a broad network of medical departments and specialists. The Intensive Care Unit is on standby for high-risk studies, enhancing safety and readiness. Groningen also offers strong recruitment potential, with a diverse and research-engaged population.

Download our company slide deck for a full overview of our facility, capabilities, and study experience.

Company Slide deck

Our management

Christine Voors-Pette, MD has been working as a Principal Investigator for over 15 years in both early- and late phase clinical research. She performed over 50 early phase clinical studies, with the majority being First-in-human trials. She is known for her straight forward approach, open communication and her commitment to clients, volunteers and coworkers.

Jitske Beukema brings a wealth of knowledge and experience within pharmaceutical and Biotech industry. She is an accomplished and proven senior executive with more than 30 years of experience in Phase I healthy volunteer and patient studies.

Agnes Boelens-van Nieff has been working for 20 years as Management Assistant/Sr. Clinical Trial Assistant/Regulatory Affairs Specialist. She will be responsible for regulatory affairs and financial affairs.